Ashwagandha (Withania somnifera (L.) Dunal) is an important Ayurvedic medicinal plant and a widely used supplement ingredient. The Ayurvedic Pharmacopoeia of India identifies the official drug as the dried mature root. Modern products may contain root, leaf, or mixed extracts with different extraction methods and withanolide concentrations, so safety findings for one preparation cannot automatically be applied to another.
The Clinical Trial Safety Picture
Most controlled human trials have been small and have lasted about six to twelve weeks. Standardized preparations were generally tolerated, while commonly reported adverse effects included stomach upset, loose stools or diarrhea, nausea, vomiting, and drowsiness. NCCIH and the NIH Office of Dietary Supplements describe short-term use, up to about three months, as the period for which the overall safety picture is most established.
Longer studies are now available, but they remain limited. A six-month pilot randomized trial tested 200 mg of a standardized root extract twice daily in 40 healthy men aged 50 to 70 years and reported no adverse effects. A 2025 prospective observational study followed 191 healthy adults taking 600 mg/day of a standardized root extract for twelve months; eighteen mild adverse events resolved without intervention, and measured hepatic, renal, and thyroid parameters showed no clinically significant deterioration.
Representative Human Safety Studies
These studies illustrate the variation in preparation, dose, duration, and design. A dose tolerated in one trial is not automatically appropriate for another extract or for a person with medical conditions.
| Study | Duration and dose | Participants | Safety finding |
|---|---|---|---|
| Langade et al., 2019 | 10 weeks; 300 mg root extract twice daily | 60 randomized; 58 completed | Described as well tolerated in a small insomnia-and-anxiety trial. |
| Lopresti et al., 2019 | 8 weeks; 240 mg/day root-and-leaf extract | 60 adults | All participants completed the trial and no adverse events were reported. |
| Verma et al., 2021 | 8 weeks; 300 mg root extract twice daily | 80 healthy adults | No adverse events or clinically important hematological, hepatic, renal, or thyroid abnormalities were reported. |
| Vaidya et al., 2025 | 6 months; 200 mg root extract twice daily | 40 healthy men aged 50–70 | Pilot randomized trial; no adverse effects were reported. |
| Salve et al., 2025 | 12 months; 600 mg/day standardized root extract | 191 healthy adults | Observational study; 18 mild events resolved and laboratory safety measures remained clinically stable. |
The six-month trial included only 40 older male participants, while the twelve-month study had no placebo group. Both tested specific standardized root extracts. They extend observation beyond the usual short trials but do not establish that every powder, concentrated extract, root-and-leaf product, or multi-ingredient formula is safe for prolonged use.
The Liver Safety Question
Ashwagandha-associated liver injury has been reported rarely, but its incidence cannot be calculated from case reports because the total number of exposed users and completeness of reporting are unknown. LiverTox classifies ashwagandha as a likely cause of clinically apparent liver injury. Reported onset is usually two to twelve weeks after starting use, commonly with a cholestatic or mixed pattern, jaundice, and itching. Recovery usually follows discontinuation, although jaundice may persist for weeks or months.
Rare acute liver failure, transplantation, and fatal acute-on-chronic liver failure have been described, particularly in people with pre-existing cirrhosis or advanced chronic liver disease. Some reports involved incompletely characterized or multi-ingredient products, but several tested products contained ashwagandha without an identified contaminant. Product quality matters, yet contamination cannot explain every reported case.
People with cirrhosis or advanced chronic liver disease should avoid ashwagandha. Stop the product and seek prompt medical assessment for yellow eyes or skin, persistent itching, unusual fatigue, nausea, or abdominal discomfort. People with other liver risks should ask a clinician whether baseline or follow-up liver testing is appropriate. Rechallenge after suspected ashwagandha-related liver injury should be avoided.
Thyroid Effects Require Caution
Ashwagandha may alter thyroid function, but it does not have a predictable thyroid-stimulating effect in every user. In a small randomized trial of 50 adults with subclinical hypothyroidism, 300 mg of root extract twice daily for eight weeks lowered TSH and increased T3 and T4 relative to placebo. This does not establish ashwagandha as a substitute for standard thyroid diagnosis or treatment.
Thyrotoxicosis has also been described in case reports, with symptoms resolving after discontinuation. The NIH Office of Dietary Supplements notes possible interaction with thyroid-hormone medicines, and NCCIH does not recommend ashwagandha for people with thyroid disorders. People with a thyroid disorder or prescribed thyroid hormone should not self-treat; any use and monitoring should be directed by the treating clinician.
Root, Leaf, and Extract Standardization
The plant part matters. The Ayurvedic Pharmacopoeia of India defines Ashvagandha as the dried mature roots of Withania somnifera. In April 2026, the Food Safety and Standards Authority of India clarified that only roots and their extracts are permitted in the covered health-supplement, nutraceutical, special-dietary-use, and special-medical-purpose food categories, and that leaves or leaf extracts are not permitted. The advisory also records a Ministry of Ayush direction that Ayush drug and product manufacturers use only roots and root extracts.
Root-only extracts, root-and-leaf extracts, powders, tinctures, and multi-ingredient products can differ in chemical profile and concentration. Results obtained with one branded extract cannot be transferred automatically to another. Prefer a product that identifies the botanical name, plant part, amount per serving, extract ratio or standardization, other ingredients, batch information, and manufacturer.
For an Ayurvedic product represented as classical Ashvagandha, preference should be given to correctly identified root material from a manufacturer following applicable pharmacopoeial and regulatory standards. See our consumer guide to Ayurvedic product labels for practical label-reading guidance.
Dosage, Duration, and Cycling
There is no single evidence-based dose for every preparation and no universally accepted safe upper intake level. Many stress and sleep trials used approximately 240 to 600 mg/day of standardized extract for six to twelve weeks, while other studies used different formulations. Milligrams of a concentrated extract are not equivalent to the same number of milligrams of plain root powder.
| Question | Verified position |
|---|---|
| Commonly studied extract range | About 240–600 mg/day in many short-term stress and sleep trials, depending on preparation. |
| Established universal upper limit | None; a dose tolerated in one trial is not a general maximum. |
| Best-established broad safety duration | Up to about three months in the short-term literature. |
| Longer-duration information | Six-month randomized and twelve-month observational data exist for specific root extracts, but broad long-term certainty remains limited. |
| Evidence-based cycling schedule | None established; “12 weeks on, 4 weeks off” is not a validated clinical rule. |
Duration should reflect the reason for use, response, product, dose, medical history, and concurrent medicines. Periodic breaks may be chosen cautiously, but they are not proven to prevent liver, thyroid, or other adverse effects. Persistent insomnia, anxiety, fatigue, or weight change deserves clinical evaluation rather than indefinite supplement use.
Drug Interactions and People Who Should Avoid It
Ashwagandha may interact with thyroid hormone, diabetes medicines, antihypertensives, immunosuppressants, sedatives, and antiseizure medicines. The magnitude of many interactions is not well quantified, but professional review is prudent because of possible additive effects on thyroid status, blood glucose, blood pressure, immune activity, or sedation.
- Pregnancy and breastfeeding: NCCIH advises avoidance during pregnancy and states that it should not be used while breastfeeding.
- Thyroid disease: Avoid unsupervised use because thyroid indices can change and interaction with thyroid hormone is possible.
- Autoimmune disease or immunosuppressive treatment: Use only with the treating clinician’s approval.
- Liver disease: Avoid in cirrhosis or advanced chronic liver disease; seek medical advice for any other liver disorder.
- Surgery: NCCIH does not recommend use for people who are about to have surgery.
- Hormone-sensitive prostate cancer: Avoid because some preparations may increase testosterone.
People taking prescription medicines should show the clinician or pharmacist the exact product label, because plant part, concentration, serving size, and accompanying ingredients can change the interaction assessment.
The Bottom Line
Standardized ashwagandha preparations are often tolerated during short-term use, with mild gastrointestinal symptoms and drowsiness the most common reported effects. Newer six-month and twelve-month observations apply to particular root extracts and do not establish lifelong safety, interchangeability among products, or a universal dose. Liver injury is rare but can be serious, and thyroid effects are clinically relevant in susceptible people.
The pharmacopoeial Ashvagandha drug is the dried mature root, whereas contemporary supplements may use differently concentrated extracts or include leaf material outside current Indian permissions for covered products. Choose a clearly identified product, avoid self-escalating the dose, stop promptly if signs of liver injury or thyrotoxicosis occur, and consult a qualified Ayurvedic practitioner and healthcare provider before use when prescription medicines, pregnancy, breastfeeding, liver disease, thyroid disease, autoimmune illness, surgery, or cancer treatment is involved.
References
- Ministry of AYUSH
- Fssai (fssai.gov.in)
- NCCIH
- NIH Office of Dietary Supplements
- Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study (2019), PubMed
- An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study (2019), PubMed
- Safety of Ashwagandha Root Extract: A Randomized, Placebo-Controlled, study in Healthy Volunteers (2021), PubMed
- Safety and Tolerability of Withania somnifera Root Extract in Healthy Male Participants: A Pilot Randomized, Double-Blind, Placebo-Controlled Clinical Trial (2026), PubMed
- Onlinelibrary (onlinelibrary.wiley.com)
- NCBI
- Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial (2018), PubMed
- Journals (journals.plos.org)
- Food (food.gov.uk)
The part about Ashwagandha Long-Term Safety feels realistic. This would be easier to follow with a one-week sample plan.
The section on thyroid interactions is the most practically important part of this article for me. I have Hashimoto’s and my endocrinologist doesn’t know much about Ashwagandha. The point that it can affect TSH levels and that people with autoimmune thyroid conditions need closer monitoring is exactly the kind of information that doesn’t make it onto supplement labels and should.
I’ve been taking a root extract standardized to withanolides for about five months now, primarily for sleep and anxiety. The sleep improvement was noticeable within two weeks. I haven’t had any bloodwork done yet to check thyroid markers, which this article reminded me I probably should. The hepatotoxicity cases mentioned are rare but the point about monitoring is well taken.
The part about Ashwagandha Long-Term Safety feels realistic. This feels more usable than a long list of herbs.
The section on contraindications was the most useful part. I have a pre-existing condition and needed that clarity.
The part about Ashwagandha Long-Term Safety feels realistic. The examples make the advice less abstract.
The part about Ashwagandha Long-Term Safety feels realistic. I would like to know how long to try it before judging results.
The six month pilot trial showing no adverse effects in older men is encouraging, but I wonder how results would differ with a leaf included extract.
My main question after reading this is about cycling. The studies mentioned are mostly 8 to 12 weeks — is there evidence either way on whether taking breaks improves or reduces long-term outcomes? My practitioner told me to take Ashwagandha for three months and then pause for one, but I haven’t found a clinical rationale for that schedule and I’m curious whether the safety data addresses it.
It would help to see a comparison of liver enzyme changes between the root only and root and leaf products over twelve months.
I noticed the article mentions that standardized preparations were generally tolerated, yet mild stomach upset and loose stools still appeared in some trials.
A practical tip is to check the label for the botanical name, plant part, and extract ratio before choosing a supplement.
Question: Does the twelve month observational study provide enough data to recommend continuous use for people with mild anxiety?
This confirmed what I was already doing intuitively. Nice to have the Ayurvedic framework to understand why.
Same here
my vaidya recommends something slightly different but the core approach is the same
I started following the protocol you described 3 weeks back. Early results are encouraging.
The comparison to modern medicine approach was helpful. My doctor and vaidya recommend different things.
I’m a Kapha type and the protocol seems designed more for Vata. Any modifications?
Doing this
tried this and the results surprised me after only 10 days
Late to this post but finding it very helpful. The practical step-by-step format makes it easy to follow.
Does this interfere with standard medications? I take something daily and want to be careful.
Will try
I’ve been dealing with this issue for 2 years and tried multiple things. Starting the approach you outlined here.
Does the treatment timeline change if you’ve had this issue long-term vs recently?
The morning routine elements you suggest are already part of my dinacharya. Adding the missing piece you mentioned now.
Useful
The specific dosage mentioned in the article, is that for adults only or does it change for elderly users?
The advice around Ashwagandha Long-Term Safety is specific enough to be useful. The practical details matter more than people think.
I wish you had included more on the Vata-specific approach. The article focuses heavily on Pitta.
Does this protocol vary by dosha type? I’m Pitta dominant and some of what you describe seems heating.
The section on diet modifications alongside the herb protocol is what makes this more complete than other guides.
The research citations are good but mostly from small studies. Would like to see larger trial data.
The historical context from Charaka Samhita grounding the recommendation was reassuring.
The quality of the herb source makes a big difference I’ve found. The article should mention what to look for when buying.
Just found this post through a search. Is the recommendation still current or has anything changed?
Does age affect how this works? I’m 52 and wondering if the protocol needs adjustment.
Just tried this for the first time this week. Too early to say but no adverse effects so far.
The historical references add credibility. Knowing this has been used for centuries matters to me.
my grandmother used to do something similar. not exactly this but the core principle was the same
Skeptical but trying anyway because conventional medicine hasn’t helped. Will report back.